About 30 Mg Octreotide For Injection
Octreotide Depot 30 mg is a top-rated, new release in anti-hormonal therapy, expertly formulated for the long-term management of acromegaly, carcinoid tumors, and VIPomas. Decorated with clinical trust, this allopathic solution contains Octreotide Acetate (30 mg), presented as a white to off-white lyophilized powder in each prime vial, accompanied by an ampoule of solvent for reconstitution. Enlightened by advanced somatostatin analogue research, Octreotide Depot offers prime relief from hormonal imbalances. Instant Checkout is available for distributors and suppliers in India. For adults, it is prescription-only, with a 24-month shelf life, and must be stored below 25C, protected from light.
Application & Suitable Use of Octreotide Depot 30 mg
For prime effectiveness, Octreotide Depot 30 mg must be reconstituted using the provided ampoule of solvent and administered as an intramuscular injection, as directed by a healthcare professional. This medication is best suited for adults requiring long-term maintenance in conditions such as acromegaly, certain neuroendocrine tumors, and VIPomas. Its use is indicated for reducing excessive growth hormone and alleviating symptoms associated with hormonal disorders, supporting enlightened clinical management in designated therapeutic areas.
Sample Policy and Prime Packaging Details for Octreotide Depot
Samples of Octreotide Depot 30 mg can be delivered to verified distributors or medical professionals as per policy terms. Each sale price covers a box consisting of 1 decorated vial and 1 ampoule of solvent, securely packaged to ensure product integrity. Orders are handed over with all necessary documentation and certifications, guaranteeing authenticity and compliance with regulatory standards. The product meets prime export requirements, demonstrating consistent quality for international and domestic supply.
FAQ's of 30 Mg Octreotide For Injection:
Q: How is Octreotide Depot 30 mg administered?
A: Octreotide Depot 30 mg is administered as an intramuscular injection after reconstituting the lyophilized powder with the solvent provided in the packaging. A physician or qualified healthcare provider should perform the preparation and administration according to the prescribed dosage.
Q: What conditions does Octreotide Depot 30 mg treat?
A: This medication is indicated for the management of acromegaly, carcinoid tumors, and VIPomas. It helps reduce excessive growth hormone levels and controls symptoms associated with specific hormonal disorders and certain neuroendocrine tumors.
Q: When should Octreotide Depot 30 mg be used?
A: Octreotide Depot 30 mg is used as a long-term maintenance therapy as directed by your physician. It is prescribed once a diagnosis of relevant hormonal conditions has been confirmed and ongoing management is required.
Q: Where should Octreotide Depot 30 mg be stored?
A: The vial and ampoule must be stored below 25C, protected from light, and never frozen. Proper storage ensures the efficacy and safety of the medicine until its 24-month shelf life expires.
Q: What is the process for reconstituting Octreotide Depot 30 mg?
A: To prepare the injection, add the provided ampoule of solvent to the vial containing the powder. Gently swirl the mixture until fully dissolved, then administer intramuscularly as prescribed by a healthcare professional.
Q: What are the benefits of using Octreotide Depot 30 mg?
A: Octreotide Depot 30 mg delivers prime control over hormonal secretion disorders, leading to symptom relief and improved quality of life for adults with acromegaly and neuroendocrine tumors. Clinical studies have demonstrated its effectiveness in sustained hormone regulation.